How Long Does Prior Authorization Take for Medication? The 2026 Provider Guide

Most medication prior authorizations take 1 to 3 business days when documentation is complete. Urgent requests are decided within 24 to 72 hours under Medicare Part D federal regulations. Specialty drugs and biologics extend that window to 5 to 14 business days. But those numbers reflect the payer’s internal decision clock. A 2026 JAMA Health Forum study of actual pharmacy claims found that once a branded medication hits an initial rejection at the pharmacy counter, the real end-to-end timeline centers around a median of 6 days for multi-day cases, with only 35 percent of prescriptions processed in 1 day.

There are two separate numbers in this topic, and most articles only give you one. The payer’s decision clock starts when the plan receives a complete request. The patient’s access timeline starts when the prescription first hits a rejection at the pharmacy counter. These are different starting points with very different endpoint lengths, and every billing team needs to understand both.

This guide covers the five-tier timeline reference, payer-by-payer breakdowns, the 2026 CMS regulatory context, how long prior authorization takes to work through once submitted, eight provider actions to speed up approvals, and the denial recovery workflow.

What Is Prior Authorization for Medication?

Prior authorization for medication is a coverage approval process in which a healthcare provider must obtain insurance company approval before prescribing certain medications. The insurer reviews the request to confirm the drug is medically necessary, meets their formulary criteria, and is appropriate for the patient’s diagnosis before they’ll agree to cover it.

Who Starts the Prior Authorization Process

The prescribing physician’s office initiates the prior authorization request. The practice’s billing team or a dedicated prior authorization specialist manages the documentation, submission, payer follow-up, and tracking. The patient doesn’t submit the PA. The pharmacy doesn’t submit the PA. When a prior authorization is required and the practice doesn’t know it or doesn’t act on it immediately, the delay clock starts the moment the patient tries to fill the prescription and receives a rejection at the pharmacy counter.

Understanding eligibility verification and prior authorization as connected workflows is what separates practices that manage PA proactively from those that react to pharmacy rejections. That understanding matters for how long does prior authorization take for medication to clear from initial request to patient access. See CMS’s prior authorization process guidance for the governing framework.

Which Medications Typically Require Prior Authorization

Brand-name medications with lower-cost generic alternatives require PA because the payer wants to confirm cheaper options were tried first. Specialty drugs including biologics, injectables, and GLP-1 medications almost always require PA because of their high cost and complex medical necessity criteria. Off-label prescriptions require PA because the drug is being used for a purpose outside its FDA-approved indication. Controlled substances with abuse potential require PA as a safeguard. High-cost cancer drugs and immunotherapy agents require PA with full clinical documentation supporting medical necessity.

How Long Does Prior Authorization Take for Medication? The 2026 Five-Tier Timeline Reference

The timeline for medication prior authorization depends on five variables: the drug type, the payer, the urgency classification, the submission method, and the completeness of the documentation packet. Here’s every official timeframe your billing team needs, organized by tier and sourced to named regulatory authority.

The 2026 Prior Authorization Timeline Table

These are the official timelines. Section 4 covers what each major payer actually delivers in practice.

The Payer Decision Clock vs the Patient Access Timeline

The payer’s decision clock starts when the plan receives a complete request. The patient’s access timeline starts when the prescription first hits a rejection at the pharmacy counter. Those are two different starting points with very different endpoint lengths.

When a patient tries to fill a specialty medication and gets a rejection, the provider’s office has to learn about it, gather documentation, submit the PA request, wait for payer review, and then the pharmacy has to reprocess the claim. Each step adds time that isn’t measured in any payer-published timeline.

The 2026 research evidence quantifies exactly how large this gap is.

The JAMA 2026 Research: What Actually Happens at the Pharmacy Counter

A cross-sectional study published in JAMA Health Forum on April 17, 2026, using 2024 IQVIA retail pharmacy claims data, measured what happens after a branded medication faces an initial prior authorization rejection at the pharmacy. The findings show that 35 percent of prescriptions were processed in 1 day. The remaining 65 percent were processed in a median of 6 days, with an interquartile range of 3 to 12 days. Prescriptions involving multiple rounds of PA review took significantly longer. The study found that 54 percent were ultimately approved.

Two operational conclusions from this data: clean first-pass submissions are the single most effective lever for getting into the 35 percent that resolve in 1 day. Multi-round submissions are the primary driver of the multi-week cases that produce patient abandonment and practice revenue loss. The full JAMA Health Forum 2026 prior authorization pharmacy claims study and the Medicare Part D prior authorization decision timeline regulations are the named regulatory sources behind these timelines.

Prior Authorization Timeline by Payer Type: What Aetna, UHC, BCBS, Cigna, and Medicare Actually Deliver

Every major payer publishes different prior authorization timelines. The data below is based on each payer’s own provider guidelines as of May 2026. These are what your billing team can reasonably expect when submissions are complete and correct.

Aetna Prior Authorization Timeline

Standard requests: 3 to 5 business days when submitted through Aetna’s electronic provider portal. Urgent requests: 24 to 72 hours if marked as expedited with supporting clinical documentation. What speeds up approval: complete CPT and ICD-10 codes submitted electronically. Common delay cause: missing progress notes or imaging reports.

UnitedHealthcare Prior Authorization Timeline

Standard requests: 3 to 10 business days depending on service complexity and documentation quality. How long does prior authorization take for medication united healthcare? Expedited requests are typically resolved within 72 hours. UHC’s provider portal allows real-time tracking. Submit all requests through the UnitedHealthcare prior authorization timeline guidelines to avoid fax delays. See the CMS-0057-F prior authorization final rule for how the January 1, 2026 regulation affects UHC’s mandate.

Blue Cross Blue Shield Prior Authorization Timeline

Standard requests: 2 to 7 business days across most BCBS state plans. Urgent reviews: 24 to 48 hours for life-threatening conditions. BCBSM states explicitly that urgent requests receive a decision within 72 hours or less, and standard non-urgent requests may take up to 7 days. Variation exists between state plans. Always submit through the plan-specific portal for fastest turnaround. When a Medicare plan misses the decision deadline and the failure is treated as an adverse determination, the resulting denial code on the remittance is typically a CO-197 denial code.

Cigna Prior Authorization Timeline

Standard prior authorization decisions are typically within 5 to 10 business days of receiving the request, per Cigna’s own published guidelines. Expedited requests are reviewed within 72 hours. Cigna’s online portal allows electronic submission and real-time status tracking, which reduces the processing window compared to fax or phone submissions.

Medicare Prior Authorization Timeline

Medicare Part D plan sponsors must respond to standard coverage determinations within 72 hours and expedited requests within 24 hours. If a plan misses the deadline, it’s treated as an adverse determination and must be forwarded to the Independent Review Entity (IRE) within 24 hours. For Medicare Advantage, CMS-0057-F (effective January 1, 2026) mandates 7 calendar days for standard requests and 72 hours for urgent requests.

Medicaid Prior Authorization Timeline

How long does prior authorization take for Medicaid? Federal Medicaid statute requires a response within 24 hours and access to a 72-hour emergency supply when PA is pending. State-specific contractor channels and incomplete documentation packets are the primary reasons Medicaid PA timelines extend beyond the statutory minimum. The proposed CMS-0062-P rule (April 10, 2026) would standardize Medicaid drug PA decisions to 24 hours if finalized.

CVS Caremark and Pharmacy Benefit Manager Timelines

How long does prior authorization take for medication cvs caremark? CVS Caremark processes standard prior authorizations within 1 to 3 business days when documentation is complete. Express Scripts reports that coverage reviews for most medications are completed within 2 business days after full documentation is received. PBM timelines are generally faster than payer-managed PA because PBM systems are more standardized and more electronically integrated.

These payer timelines apply when the request is complete and correct. The next section covers the two 2026 regulatory rules that are forcing payers to comply with mandated decision windows for the first time in US healthcare history.

One O Seven RCM’s billing team tracks payer-specific prior authorization requirements, portal submission rules, and documentation standards for every major payer, so your practice doesn’t have to maintain a separate payer rule database.

How Long Does Prior Authorization Take for Zepbound, Ozempic, and Wegovy in 2026?

GLP-1 receptor agonists including Ozempic, Wegovy, and Zepbound have become the fastest-growing prior authorization category in US healthcare. Their PA timelines are specific enough to warrant their own reference, and 2026 is the first year official data is available.

Why GLP-1 Medications Have Their Own PA Timeline Category

GLP-1 medications are specialty-tier, high-cost, non-formulary in many plans, and often subject to step therapy requirements that add documentation layers not required for standard medications. When a patient’s plan requires proof of failed first-line weight management attempts before approving Wegovy or Zepbound, that documentation review adds days to the PA process on top of the standard review period. Many payers also require specific BMI thresholds, documented comorbidities, or prescriber specialty criteria. Meeting all of these criteria in the initial submission is the difference between a 1-day approval and a 10-day review cycle.

Official 2026 PA Timeline Data for Semaglutide

Washington State’s Office of the Insurance Commissioner published official plan-year 2024 prior authorization response time data on January 1, 2026. For semaglutide, which includes Ozempic, Rybelsus, and Wegovy, the average standard response time across 14 carriers was 35.2 hours across 16,610 standard requests. The range across all drug categories in the report was 0.4 hours to 60 hours. This is the only official government-published drug-specific PA timeline dataset available for 2026 and the most specific named source for GLP-1 PA timelines in any RCM article. See the full Washington State 2026 official prior authorization response time data for the complete carrier-by-carrier breakdown.

Zepbound (Tirzepatide) Prior Authorization Timeline

How long does prior authorization take for Zepbound? Zepbound is tirzepatide approved for chronic weight management. Most commercial plans treat Zepbound as a specialty-tier medication requiring full prior authorization with documented obesity diagnosis, BMI criteria, and prior treatment failure documentation. Standard PA timelines for Zepbound range from 5 to 10 business days at most major commercial payers when documentation is complete. Expedited requests citing urgent clinical need are decided within 72 hours. How long does prior authorization take for Wegovy? The documentation packet for Wegovy and Zepbound is more complex than standard specialty drugs because payers frequently require evidence that behavioral interventions were attempted first.

The 2026 Prior Authorization Rules That Are Changing Medication Approval Timelines Right Now

Two major regulatory events in 2026 are reshaping how long does prior authorization take for medication across every payer class. One is already in effect. One is proposed and will take effect in 2027 if finalized. Every billing team working medication PAs needs to understand both.

CMS-0057-F (January 1, 2026): What It Does and Does Not Cover for Medication PA

CMS-0057-F, the CMS Interoperability and Prior Authorization Final Rule, went into effect January 1, 2026. It mandates that Medicare Advantage, Medicaid managed care, CHIP managed care, Medicaid FFS, CHIP FFS, and QHP plans on federal exchanges respond to prior authorization requests within 7 calendar days for standard requests and 72 hours for urgent requests. It also requires payers to provide a specific reason for every denial.

Critical billing team note: CMS-0057-F does NOT apply to drug prior authorizations. The rule covers medical items and services only. Medication PA timelines are governed by existing Medicare Part D regulations and Medicaid statute, not CMS-0057-F. The specific denial reason requirement in CMS-0057-F changes how billing teams work prior authorization denial recovery. When payers must state exactly why a PA was denied, appeals can be targeted directly at the stated reason rather than submitting general medical necessity arguments.

CMS-0062-P (April 10, 2026): The Proposed Drug PA Rule Coming in 2027

On April 10, 2026, CMS released the Interoperability Standards and Prior Authorization for Drugs proposed rule (CMS-0062-P). The proposal would require QHP plans on federal exchanges to respond to standard drug PA requests within 72 hours and urgent requests within 24 hours. Medicaid MCOs and FFS programs would be required to respond within 24 hours for all drug PA requests. Read the full CMS-0062-P prior authorization for drugs proposed rule for comment details.

If finalized, compliance begins October 1, 2027. The public comment period closes June 15, 2026. Until then, drug PA timelines remain governed by Medicare Part D regulations (72 hours standard, 24 hours expedited) and Medicaid statute (24 hours). See the full CMS-0057-F prior authorization final rule for the medical services distinction.

What the HHS Voluntary Insurer Pledge Means for Your Practice Now

In June 2025, the Department of Health and Human Services announced that six major payers pledged to improve prior authorization voluntarily: United Healthcare, Aetna, Cigna, Humana, Blue Cross Blue Shield, and Kaiser Permanente. Their commitments include approving at least 80 percent of electronic PA requests in real time by 2027, requiring prior authorizations for fewer claims, and providing clear explanations for all denials.

In April 2026, AHIP reported that leading health plans have already eliminated 11 percent of prior authorizations, representing 6.5 million fewer PA requests for patients. One major plan committed to eliminating PA requirements for 30 percent of healthcare services. The full AHIP April 2026 prior authorization progress report details each insurer’s measurable progress.

The CMS Electronic Prior Authorization Acceleration Initiative (May 13, 2026)

On May 13, 2026, CMS announced the Electronic Prior Authorization Acceleration Initiative with 29 healthcare organizations as early adopters. Named participants include health systems (AtlantiCare, Cleveland Clinic, Ochsner Health, Providence, Rush University), payers (Aetna, Blue Shield of California, Cigna, Elevance Health, Humana, UnitedHealthcare), and EHR developers (athenahealth, eClinicalWorks, Epic, MEDITECH, Oracle). The initiative targets real-time electronic PA integration into clinical workflows ahead of the 2027 FHIR API mandate.

One O Seven RCM tracks every CMS regulatory update affecting prior authorization timelines and updates our submission workflows as soon as new rules take effect, so your practice is always operating under current rules, not last year’s guidelines.

Why Medication Prior Authorization Takes Longer Than It Should: Six Root Causes

Most delays in how long does prior authorization take for medication are preventable. They trace back to six operational root causes that billing teams can address before the first submission leaves the office. Here’s what causes each category of delay and what the data says about how common each is.

Cause 1: Incomplete Documentation at Submission

Incomplete documentation is the number one cause of PA delays across all drug types and all payers. When diagnosis codes don’t clearly support the requested service, when progress notes are missing, or when prior treatment history isn’t attached, payers pause the review and request more information. Each documentation request adds an average of 2 to 5 business days to the process. The 2026 JAMA Health Forum study found that prescriptions involving multiple rounds of PA review were significantly less likely to be processed in 1 day. First-pass complete submission is the single most effective lever your billing team controls.

Cause 2: Manual Submission Instead of Electronic

Fax and phone submissions add 2 to 3 business days compared to electronic prior authorization on average. EZMDSolutions reports that medical offices using electronic systems obtain approvals 30 to 50 percent faster than those using fax or mail. SPRY’s 2026 data shows ePA averages 3 minutes and 54 seconds for an electronic response, compared to 2 to 5 business days for manual fax. How long does preauthorization take for medication when your team is still faxing? The submission method your team uses is directly adding days to every medication approval. How long does a prior authorization take to clear is a very different question when ePA is in use versus fax.

Cause 3: Step Therapy Requirements Not Met

Step therapy requires patients to try a lower-cost medication before the insurer approves the preferred drug. When the prior authorization packet doesn’t document that step therapy requirements were attempted or that the patient is clinically exempt, the payer denies the PA or requests additional documentation. This is where billing teams need solid eligibility verification and prior authorization documentation to confirm step therapy status before submitting. For specialty medications like GLP-1 drugs, step therapy documentation alone adds 5 to 10 business days to the review cycle when it’s missing from the initial submission. A CO-50 denial code on the remittance often indicates step therapy criteria weren’t satisfied on the original claim.

Cause 4: Payer-Specific Criteria Not Followed

Every payer has different PA requirements for the same drug. UHC requires specific clinical criteria that differ from Aetna’s criteria for the same GLP-1 medication. When a billing team submits a generic PA packet that doesn’t address the payer’s specific formulary criteria, the payer returns the request with clarification questions. Tracking payer-specific requirements in a drug-by-drug, payer-by-payer matrix and updating it quarterly is the structural solution.

Cause 5: Missing or Expired Authorization Number

When a prior authorization is approved but the authorization number isn’t included on the claim, payers issue a CO-197 denial code even though the authorization exists. When an authorization expires before the service is delivered, the practice must restart the prior authorization process from scratch. 25 percent of PA approvals expire before the renewal is submitted, according to SPRY 2026 data. Authorization tracking and renewal management are separate workflows from PA submission, and most practices understaff both.

Cause 6: Staffing and Capacity Constraints

The AMA’s 2025 Prior Authorization Physician Survey, released May 13, 2026, found that physicians complete an average of 39 prior authorizations per week and spend 13 hours on the process. The MGMA 2025 prior authorization landscape report found that 60 percent of practices require at least three employees to complete a single PA request, and 35 percent spend over 35 minutes per request. When PA volume exceeds the practice’s capacity to manage it, delays aren’t a documentation problem. They’re a staffing structure problem. See the full AMA 2025 Prior Authorization Physician Survey for the complete administrative burden data released May 13, 2026.

When prior authorization volume is outpacing your billing team’s capacity, One O Seven RCM’s dedicated PA specialists take the entire submission, tracking, and follow-up workflow off your staff so your team can focus on patient care.

How to Speed Up Prior Authorization for Medication: Eight Actions That Actually Work

The gap in how long does prior authorization take for medication between a 1-day and 10-day review cycle almost always comes down to what your team did before submission, not what the payer does during review. These eight actions address the root causes identified in the 2026 research and cut medication PA timelines measurably.

Action 1: Submit Electronically Every Time

Electronic prior authorization reduces processing time by up to 69 percent compared to manual fax, according to SPRY 2026 data. Electronic systems average 3 minutes and 54 seconds for a response when requests meet the payer’s criteria automatically. Most major payers including Aetna, UHC, BCBS, and Cigna have secure provider portals for electronic PA submission. See the CMS electronic prior authorization guidance for the regulatory framework behind ePA adoption. If your practice is still faxing PA requests, that workflow is adding 2 to 3 business days to every medication approval.

Action 2: Build First-Pass Complete Documentation Packets by Drug Class

Create a documentation checklist for each drug class your practice frequently prescribes: GLP-1 medications, biologics, specialty injectables, and controlled substances. Each checklist should map the required elements to the top five payers your patients use. Diagnosis codes, prior treatment history, lab results, clinical notes, and prescriber attestation should all be attached on the first submission. The JAMA 2026 study found that prescriptions requiring multiple submission rounds were far less likely to be processed in 1 day. How long does prior authorization for medication take is determined by what goes into the first submission packet.

Action 3: Know the Difference Between Standard and Expedited

Requesting expedited review when the clinical criteria are met reduces the decision window from 3 to 7 business days to 24 to 72 hours. The legal standard for expedited review under Medicare Part D is whether waiting for a standard decision could seriously jeopardize the patient’s life, health, or ability to regain maximum function. When these criteria apply, mark the request as expedited and document the clinical urgency in the submission. The how to speed up prior authorization for medication answer often starts here: expedited classification is underused by most practices.

Action 4: Track Payer Portals Daily, Not Weekly

PA requests sitting unreviewed in a payer’s portal because no one followed up are the most preventable source of multi-week delays. Assign someone in the billing team to check portal status on every pending PA every business day. When a payer issues an information request, a same-day response keeps the process moving. A 48-hour response time to an information request adds 48 hours to the approval timeline and sometimes resets the review clock.

Action 5: Request Peer-to-Peer Review When Appropriate

When a prior authorization is denied and the prescriber believes the medical necessity is clear, a peer-to-peer review allows the prescribing physician to discuss the case directly with the payer’s medical director. Over 80 percent of initial prior authorization denials are overturned during the appeal process when a physician provides proper medical justification. Peer-to-peer review is the fastest path to overturning a denial for specialty medications where clinical nuance matters.

Action 6: Build a Step Therapy Documentation Library

Maintain records of every medication trial, including drug name, dosage, duration, and documented reason for discontinuation. When a payer requires evidence of step therapy compliance before approving a specialty drug, having these records organized and ready eliminates the documentation gap that causes 5 to 10 additional business days on GLP-1 and biologic PA requests. How to speed up prior authorization is directly tied to how ready your step therapy records are before the first submission.

Action 7: Manage PA Renewals Before Expiration

25 percent of PA approvals expire before the renewal is submitted, according to SPRY 2026 data. When an authorization expires, the practice must restart the entire PA process from the beginning, adding the full approval timeline to the patient’s access delay. Set calendar alerts 30 days before every authorization expiration date and assign renewal submissions as a tracked task with a named owner.

Action 8: Assign a Dedicated PA Specialist or Partner

40 percent of larger physician practices have staff working exclusively on prior authorizations. Specialty practices managing high volumes of GLP-1, biologic, or specialty injectable prescriptions need a dedicated function, not a shared administrative task. When PA volume exceeds what one team member can manage, a dedicated prior authorization services partner or a medical billing virtual assistant with PA expertise consistently reduces approval timelines because prior authorization management is their only focus.

One O Seven RCM’s prior authorization team manages submission, payer follow-up, documentation tracking, and renewal management for practices that want faster medication approvals without adding headcount.

What to Do When a Medication Prior Authorization Is Denied

Most denials on how long does prior authorization take for medication to resolve are reversible. Over 83 percent of Medicare Advantage appeals succeed, per KFF data. But the appeal only succeeds when it addresses the specific stated denial reason with targeted documentation. Here’s the five-step process.

Step 1: Read the Denial Reason Before Taking Any Action

CMS-0057-F (effective January 1, 2026) requires payers to provide a specific reason for every prior authorization denial. Read it before drafting any appeal. The denial reason tells your billing team exactly what documentation was missing, what criteria weren’t met, or what payer policy the request didn’t satisfy. A general medical necessity letter that doesn’t address the specific stated reason fails most appeals before the payer even reads the clinical content. For prior authorization denial recovery using the denial reason as the targeting mechanism, your appeal needs to mirror the stated criteria gap with direct evidence.

Step 2: File an Internal Appeal With Stronger Documentation

Submit an internal appeal within the payer’s stated deadline. Attach the specific documentation that addresses the denial reason: updated clinical notes, lab results, prior treatment history, or a prescriber letter of medical necessity that cites the payer’s own formulary criteria. Your denial management services workflow should include a checklist for each payer’s appeal requirements. Appeals that mirror the payer’s stated criteria with the payer’s own language win significantly more often than generic appeals.

Step 3: Request a Peer-to-Peer Review

When the prescriber’s clinical judgment is the deciding factor, peer-to-peer review allows the prescribing physician to discuss the case directly with the payer’s medical director. Most payers complete peer-to-peer reviews within 2 to 5 business days. Peer-to-peer is particularly effective for specialty medications where clinical nuance (comorbidities, contraindications, prior treatment failures) isn’t fully captured in documentation alone. Understanding top denial codes in medical billing helps your team triage which denials warrant peer-to-peer versus standard appeal.

Step 4: Request Expedited External Review When Appropriate

When the internal appeal fails and the medication is urgent or life-threatening, patients have the right to request an external independent review. Under the Affordable Care Act, insurers must comply with external review decisions. For Medicare Part D, the Independent Review Entity (IRE) must decide expedited requests within 72 hours. Standard external reviews typically take 30 to 60 days. The full KFF Medicare Advantage prior authorization appeal success rates give billing teams a benchmark for expected overturn rates by payer category.

Step 5: Consider a Formulary Alternative While the Appeal Is Pending

When the appeal timeline would delay patient access to critical medication, the prescriber may consider switching to a formulary-listed alternative that doesn’t require PA. This isn’t giving up on the appeal. It’s protecting patient access while the administrative process plays out. Many payers will also retroactively approve a PA when the appeal succeeds, allowing the practice to resubmit and recover the original medication costs.

One O Seven RCM’s denial management team handles PA appeal drafting, peer-to-peer coordination, and external review submissions so your billing staff doesn’t spend 35 minutes per request on a process that requires specialist knowledge to win.

How Long Does a Prior Authorization Stay Valid? Validity Periods and Renewal Timelines

A prior authorization approval doesn’t last forever. Validity periods vary by drug type, payer, and whether the medication is for a chronic or acute condition. Here’s what your billing team needs to track.

Medication Prior Authorization Validity Table

25 percent of PA approvals expire before the renewal is submitted, per SPRY 2026 data. That’s a fully preventable revenue gap.

What Happens When a Prior Authorization Expires

When a prior authorization expires before the claim is submitted, the payer adjudicates the claim as if no authorization exists. The remittance returns a CO-197 denial code. The practice must restart the prior authorization process from the beginning and re-obtain approval before resubmission. The revenue is delayed by the full PA timeline again plus the claim resubmission window. How long do prior authorizations last, and how long does a prior authorization last before it requires reauthorization are the two renewal management questions every billing team needs to answer per drug class and per payer before the authorization fires. An expired authorization isn’t a small administrative error. It’s a revenue cycle failure that doubles the total approval wait time.

What Medication Prior Authorization Is Really Costing Your Practice in 2026

Prior authorization isn’t just a clinical delay. It’s a measurable revenue cycle cost that compounds every month your practice doesn’t have a structured PA workflow. The May 2026 AMA data puts specific numbers on what most practices are absorbing silently.

The AMA 2025 Survey Data: What Prior Authorization Is Costing Physicians Right Now

The AMA 2025 Prior Authorization Physician Survey, released May 13, 2026, surveyed physicians across all specialties. Every finding below is from that named source.

95 percent of physicians say PA delays access to necessary care. 26 percent report that PA has led to a serious adverse event including hospitalization, permanent impairment, or death. 79 percent report that patients abandon treatment due to PA challenges. 92 percent say PA negatively affects clinical outcomes. 80 percent report that patients pay out of pocket for medications because of PA delays and denials. Physicians complete an average of 39 prior authorizations per week and spend 13 hours per week on the process. The estimated annual administrative cost per physician is $34,000 and 700 hours of time. Only 33 percent of physicians believe the insurer voluntary pledge will make a meaningful difference.

What That Means for Your Practice’s Revenue Cycle

At 13 hours per week per physician, a three-physician practice is spending 39 hours per week on prior authorization administration. That’s nearly a full-time employee’s workload dedicated entirely to getting permission to treat patients. At $34,000 per physician annually, a five-physician practice is spending $170,000 per year in administrative costs on PA alone. These costs don’t appear as a line item on your P and L. They appear as staff time, physician burnout, patient abandonment, and delayed collections.

A structured PA workflow that moves submissions electronically, tracks renewals automatically, and manages denials systematically doesn’t just cut approval timelines. It recovers those hours and those dollars for the practice. Your revenue cycle management services workflow should include PA as a tracked revenue cycle function, not an afterthought. PA denials that age into AR are exactly the type of claim that requires AR follow-up services to recover before the timely filing window closes.

One O Seven RCM’s prior authorization services handle submission, tracking, denial management, and renewal for a practice’s entire PA volume, recovering the administrative hours your physicians and billing staff are currently spending on the process every week.

Frequently Asked Questions About Medication Prior Authorization

How long do prior authorizations take for medications?

Most medication prior authorizations take 1 to 3 business days when documentation is complete. Urgent requests are decided within 24 to 72 hours. Specialty drugs and biologics take 5 to 14 business days. But the real-world timeline after a pharmacy rejection is longer. A 2026 JAMA Health Forum study found that 65 percent of branded medication PA cases took a median of 6 days once multiple review rounds were required.

Do prior authorizations usually get approved?

Yes. Over 83 percent of Medicare Advantage prior authorization appeals succeed, per KFF data. Ultimate approval rates including appeals range from 85 to 95 percent depending on medical specialty and payer type. Initial denial rates are higher, but most initial denials are reversed when the appeal targets the specific stated denial reason with complete clinical documentation. CMS-0057-F (January 1, 2026) now requires payers to state a specific denial reason, which makes targeted appeals significantly more effective.

How can I speed up prior authorization for medication?

Submit electronically through the payer’s portal instead of fax. Attach all required documentation on the first submission. Request expedited review when the clinical urgency standard is met. Follow up on pending requests daily, not weekly. Assign a dedicated PA specialist or RCM partner to manage the process. Electronic submission reduces approval time by up to 69 percent compared to manual fax, per SPRY 2026 data.

What is the average wait time for prior authorization?

The payer’s decision clock averages 1 to 3 business days for standard medications. The patient’s actual access timeline after a pharmacy rejection averages a median of 6 days for cases requiring multiple review rounds, per the 2026 JAMA Health Forum study using IQVIA pharmacy claims data. These are two different measurements and both are true depending on where you start counting.

Who is responsible for getting prior authorization for medication?

The prescribing physician’s office initiates the prior authorization request. The practice’s billing team or a dedicated prior authorization specialist manages documentation, submission, payer follow-up, and tracking. Patients don’t submit PA requests. Pharmacies don’t submit PA requests. When no one in the practice owns the process, medication PA delays default to the longest possible timeline because nobody’s following up. One O Seven RCM’s prior authorization services take full ownership of the process for your practice.

How many prior authorizations are denied?

For Medicare Advantage, 28.8 percent of prior authorization requests were denied in 2023, representing approximately 50 million total requests, per KFF data. The AMA’s 2025 survey found that 32 percent of physicians report PA requests are often or always denied. The 2026 JAMA Health Forum study found that only 54 percent of branded medications facing an initial PA rejection at the pharmacy were ultimately approved.

What is the prior authorization process for prescription drugs?

The prescribing physician submits a prior authorization request to the insurer with clinical documentation supporting medical necessity. The payer reviews the request against their formulary criteria and coverage policy. The payer approves, denies, or requests additional information within the applicable regulatory timeline. When approved, the authorization number is documented and included on the claim. When denied, the practice has the right to appeal with stronger documentation or request peer-to-peer review. Learn more in our eligibility verification and prior authorization billing guide.

How long does a prior authorization stay valid?

Prior authorization validity periods range from 30 days for one-time acute medications to 12 months for chronic maintenance drugs. Specialty medications including biologics and GLP-1 drugs are typically valid for 3 to 12 months depending on the payer. 25 percent of PA approvals expire before the renewal is submitted, per SPRY 2026 data, creating an entirely preventable revenue gap that restarts the full PA timeline.

Why does prior authorization take so long?

Most medication PA delays trace to six causes: incomplete documentation at submission, manual fax submission instead of electronic, step therapy requirements not documented, payer-specific criteria not addressed, authorization numbers missing from claims, and insufficient PA staffing capacity. The AMA found physicians spend 13 hours per week on PA. When billing teams are managing PA volume without dedicated processes, every review round adds days to the patient access timeline.

What happens if a prior authorization for medication is denied?

When a prior authorization is denied, the practice can file an internal appeal, request a peer-to-peer review, or request external independent review for urgent cases. CMS-0057-F (January 1, 2026) requires payers to state a specific denial reason, which allows billing teams to target appeals directly at the stated deficiency. Over 83 percent of Medicare Advantage appeals succeed when proper documentation is submitted. One O Seven RCM’s denial management services manage the full appeal workflow.

How long does prior authorization take for Zepbound?

Zepbound (tirzepatide) prior authorization typically takes 5 to 10 business days at most commercial payers when documentation is complete. Expedited requests citing urgent clinical need are decided within 72 hours. Most payers require documented obesity diagnosis, BMI criteria, and evidence that behavioral interventions were attempted before approving Zepbound, making first-pass complete documentation especially important for this drug class.

What is the difference between standard and expedited prior authorization?

Standard prior authorization is reviewed within 1 to 7 business days depending on the payer and drug type. Expedited prior authorization applies when the prescriber certifies that waiting for a standard decision could seriously jeopardize the patient’s life, health, or ability to regain maximum function. Under Medicare Part D federal regulations, expedited requests must be decided within 24 hours. Payers cannot deny expedited status without clinical justification.